- Home
- / Our solutions /
- Policy & System Navigation
Policy & system navigation
We can help influence the access landscape for your company or product while creating shared alignment with your stakeholders.
Kintiga’s health policy and stakeholder communications experts will address potential challenges, mitigate risks, and optimise opportunities across the political and healthcare landscape to support patient access. The team has an in-depth understanding of the access and uptake environment and has experience working across a range of therapeutic areas, as well as relationships with key decision makers in government, regulatory bodies, HTA bodies, and Patient Advocacy groups
What we can offer you
Kintiga’s relationships with key stakeholders can help create strategic, nuanced engagement with relevant stakeholders to build trust, inform decisions, and ensure that opportunities for collaboration are maximised.
We work with clients to identify objectives that are based on the policy environment including:
- Strategic planning, positioning and message development
- Political, economic, social, and technological analysis to help strategic and operational business planning
- Bespoke policy analysis to identify opportunities and risks, advisory boards to provide clinical and stakeholder insights
- Tailored monitoring of policy and stakeholder developments
- Influencing policy through reports, consultation responses and briefings
- Evidence-based thought leadership and collaborative policy development
- Stakeholder mapping and prioritisation based on relevance and influence
- Stakeholder engagement, political and media communications
- Organising and attending roundtables, seminars, conferences and parliamentary events
- Policy and Public Affairs training
Delivering impact through excellence
Results speak louder than words. At Kintiga, our track record of success demonstrates our ability to deliver impactful market access strategies that align with your ambitions.
Let’s have a chat
We pride ourselves to have a personal relationship with our network of stakeholders, opinion leaders and clients, and we would love to get to know you as well. Feel free to reach out for a chat.
Malcolm Boyd
Consultant, Policy and Public Affairs
Featured case studies
Delivering a Successful SMC Re‑Submission Through Strategic Alignment and Rapid Cross‑Functional Execution
Faster, Fairer, Broader: What NICE’s 2025–26 Annual Report Means for Market Access
NICE’s New Rulebook for Obesity Health Economics: What PMG50 Means for Modellers
PMI Pharma Summit
NICE Conference 2026
Poster Presentation: Increased trends of self-optimised submissions to NICE (HTA 199)
Our expertise:
UK and Ireland Access Consultancy
Our UK and Ireland team provide tailored strategic guidance and end-to-end support across development, launch, and lifecycle management, aligned with NICE, SMC, AWMSG, and NCPE pathways and evolving HTA expectations.
UK and Ireland Market Access Pathways
Success starts with a clear launch pathway. Kintiga offers UK and Ireland expertise, supporting NICE, SMC, AWMSG, and NCPE submissions with strong evidence alignment, payer negotiation, and stakeholder engagement to drive positive outcomes.
EU HTA Strategy Support
With extensive NICE submission experience, Kintiga is well positioned to support Joint Clinical Assessments, offering integrated solutions from JSC advice to JCA reporting for successful EU HTA outcomes.
Health Economics and Outcomes Research
Our Health Economists build and adapt economic models for the UK and Ireland, integrating local data, comparators, and care pathways. We also develop early pricing and access models to guide investment and evidence strategies aligned with payer expectations.
Pricing Strategy
Kintiga analyses pricing landscapes and benchmarks competitors to shape early pricing strategies. We integrate value messaging and design long-term frameworks like risk-sharing and managed entry agreements to ensure sustainable UK and Ireland market access.
Policy and Systems Navigation
Kintiga monitors policy changes across NHSE, DoH, HSE, and regional bodies to assess their impact on your product. We provide strategic engagement with key institutions and support managed access, conditional reimbursement, and policy initiatives to optimise market entry and sustainability.
Contact us
Ready to unlock your product’s potential in Europe’s complex healthcare landscape? Contact Kintiga today to discover how our market access strategy expertise can drive measurable impact for your product.
